Bracco reports cardiac PET growth

Contrast agent developer Bracco Diagnostics said that the number of customers using its CardioGen-82 cardiac PET myocardial perfusion imaging (MPI) tracer has increased by 46% in comparison with June of 2009.

The Princeton, NJ-based vendor attributed the growth to increasing momentum for cardiac PET, publication of key clinical data, improvements in PET hardware/software technology and accessibility, and expanding society and academic advocacy for MPI.

Related Reading

VisualSonics, Bracco debut new software, April 19, 2010

Bracco expands to Korea, April 16, 2010

GE, Bracco receive FDA violation notices, January 25, 2010

Judge gives Bracco partial victory in patent case, August 28, 2009

Bracco debuts new CardioGen pump at SNM show, June 15, 2009

Copyright © 2010

Page 1 of 436
Next Page